0000899243-22-012779.txt : 20220330
0000899243-22-012779.hdr.sgml : 20220330
20220330160019
ACCESSION NUMBER: 0000899243-22-012779
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220314
FILED AS OF DATE: 20220330
DATE AS OF CHANGE: 20220330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barclay Alec
CENTRAL INDEX KEY: 0001734339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 22786332
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-14
0
0001492674
T2 Biosystems, Inc.
TTOO
0001734339
Barclay Alec
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Operations Officer
Common Stock
2022-03-14
4
M
0
21666
A
180421
D
Common Stock
2022-03-14
4
F
0
11428
0.364
D
168993
D
Restricted Stock Units
2022-03-14
4
M
0
21666
0.00
D
Common Stock
21666
21667
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
11,428 shares of common stock were automatically withheld at vesting to cover required tax withholding.
On March 14, 2020 the reporting person was granted 65,000 that vest in three equal annual installments commencing on March 14, 2021.
/s/ John Sprague, Attorney-in-fact
2022-03-30